BioSpace News Archive

The study showed improvement on both gas and bloating scores from the test subjects and notably, was more effective in the male subpopulation.

The report, global point of care diagnostics market has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on product, end-users, and geography for the forecast period 2019-2023.

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2019 of $0.95 per share on the company’s common stock

POXEL S.A. (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today that it will be featured as a presenting company at the H.C. Wainwright 3rd Annual NASH Investor Conference and the Company will provide an overview of its two clinical stage candidates, PXL770,

AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications, announced the publication of an article titled “Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment” in the journal Biomedicines.

Clarion, a life sciences strategy and organizational consultancy, today announced that Managing Director and Founder, Bart Lombardi will moderate a panel at CBI’s 5th Annual Bio/Pharmaceutical Product Commercialization and Launch Roadmap on Evolving Go-To-Market Strategies for Successful New Product Launch in 2020 & Beyond.

Elite Dental Partners has named Gaurav Bhattacharyya as CEO. Bhattacharyya has been President of EDP since July.

On October 13, 2019, California Governor Gavin Newsom signed Assembly Bill 1519 into law, granting the California Dental Board continued authority to oversee and regulate dental services in the state.

Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release financial results for the third quarter 2019 after the close of trading on Thursday, November 7, 2019.

Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the results and answer questions.